DANIEL MUSTER: Open Payments
NPI 1124751045 · LEHI, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$188 in 5 payments from 5 companies in 2025. Trend: 2023 $351 · 2024 $180 · 2025 $188
Food & beverage: $188
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $120 |
| Alkermes, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: REXULTI, LYBALVI, TRINTELLIX, VRAYLAR, COBENFY.
Industry payments across UT — which companies pay providers there.
